NCT03461562

Brief Summary

Purpose of the study will investigate the effects of two different training programs on hepatic steatosis and physical fitness parameters. This trial is designed in a randomized controlled study plan and aerobic training (40 minutes) wil be combined with Whole Body Vibration Training (WBVT for 15 minutes) which is made up of a shorter time application. WBVT to be applied instead of the resistance exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 12, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 6, 2018

Status Verified

August 1, 2018

Enrollment Period

6 months

First QC Date

February 27, 2018

Last Update Submit

August 3, 2018

Conditions

Keywords

Aerobic ExerciseWhole Body Vibration Therapy

Outcome Measures

Primary Outcomes (1)

  • FibroScan

    İn the Fibroscan measurement session, the patient lying supine, the tip of the transducer is placed on the skin between the ribs over the right lobe of the liver. At least 10 validated measurements with a ratio of interquartile range (IQR) and median LSM of less than or equal to 30 percent are required for an interpretation of significant fibrosis or cirrhosis.

    8 weeks

Secondary Outcomes (1)

  • Profile of liver enzymes

    8 weeks

Other Outcomes (3)

  • Body composition

    8 weeks

  • Cardiopulmonary exercise testing

    8 weeks

  • Body Fat Percentage

    8 weeks

Study Arms (2)

Experimental

EXPERIMENTAL
Other: Aerobic Exercise

Control

ACTIVE COMPARATOR
Other: Aerobic Exercise

Interventions

Aerobic exercise wil be held for 40 minutes. Dynamic exercises will be accompanied by physiotherapist on the vibration platform for 15 minutes. Same excercises will be held stable platform (when the devices turned off) by control group for 15 minutes.

Also known as: Whole Body Vibration Therapy
ControlExperimental

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of NAFLD
  • Age range of 18-65 years
  • Participants who are not in an active exercise program
  • Participants who are not on an active diet program

You may not qualify if:

  • Pregnancy
  • Chronic inflammatory process
  • Rheumatic disease
  • Cognitive disorders
  • Obstacles to achieve physical performance tests
  • Presence of other conditions that may cause liver steatosis
  • Inability to do WBVT or Aerobic Exercises

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, 34000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Exercise

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Fatma Mutluay, Professor

    Medipol University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 27, 2018

First Posted

March 12, 2018

Study Start

January 5, 2018

Primary Completion

June 30, 2018

Study Completion

August 1, 2018

Last Updated

August 6, 2018

Record last verified: 2018-08

Locations